---
figid: PMC7826465__CAM4-10-337-g007
figlink: pmc/articles/PMC7826465/figure/cam43621-fig-0007/
number: F7
caption: Schematic representation of the molecular mechanism in the suppression of
  ovarian cancer malignancy by lidocaine. Ovarian cancer cells expressing high NaV1.5
  level present strong capacity of intraperitoneally implanted metastasis. Lidocaine
  binding with NaV1.5 blocks the activation of FAK/Paxillin signaling pathway, inhibits
  the proliferation and metastasis, and decreases cisplatin resistance of ovarian
  cancer cells. The voltage‐gated sodium channels (VGSCs) blocker, tetrodotoxin (TTX),
  or FAK inhibitor (FAKi) reduces ovarian cancer malignancy by inactivating FAK/Paxillin
  signaling pathway
pmcid: PMC7826465
papertitle: Lidocaine inhibits the metastatic potential of ovarian cancer by blocking
  NaV1.5‐mediated EMT and FAK/Paxillin signaling pathway.
reftext: Chang Liu, et al. Cancer Med. 2021 Jan;10(1):337-349.
pmc_ranked_result_index: '1118'
pathway_score: 0.9338847
filename: CAM4-10-337-g007.jpg
figtitle: Molecular mechanism in the suppression of ovarian cancer malignancy by lidocaine
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7826465__CAM4-10-337-g007.html
  '@type': Dataset
  description: Schematic representation of the molecular mechanism in the suppression
    of ovarian cancer malignancy by lidocaine. Ovarian cancer cells expressing high
    NaV1.5 level present strong capacity of intraperitoneally implanted metastasis.
    Lidocaine binding with NaV1.5 blocks the activation of FAK/Paxillin signaling
    pathway, inhibits the proliferation and metastasis, and decreases cisplatin resistance
    of ovarian cancer cells. The voltage‐gated sodium channels (VGSCs) blocker, tetrodotoxin
    (TTX), or FAK inhibitor (FAKi) reduces ovarian cancer malignancy by inactivating
    FAK/Paxillin signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SCN5A
  - PTK2
  - Lidocaine
  - TTX
  - Cisplatin
  - Ovarian cancer malignancy
genes:
- word: Nav1.5
  symbol: Nav1.5
  source: hgnc_alias_symbol
  hgnc_symbol: SCN5A
  entrez: '6331'
- word: Nav1.5
  symbol: Nav1.5
  source: hgnc_alias_symbol
  hgnc_symbol: SCN5A
  entrez: '6331'
- word: Nav1.5
  symbol: Nav1.5
  source: hgnc_alias_symbol
  hgnc_symbol: SCN5A
  entrez: '6331'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
chemicals:
- word: Lidocaine
  source: MESH
  identifier: D008012
- word: TTX
  source: MESH
  identifier: C104261
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases:
- word: Ovarian cancer malignancy
  source: MESH
  identifier: D010051
figid_alias: PMC7826465__F7
redirect_from: /figures/PMC7826465__F7
figtype: Figure
---
